Emeritus профессор obstetrics и Gynecology и психиатрии Школа университета Yale микстуры Новый Haven, CT (США) Др. Philip M Саррел, MD будет в настоящее время emeritus профессором obstetrics и Gynecology и психиатрией на школе университета Yale микстуры в новом haven, connecticut. Он был назначен к факультету Yale в 1969 и оставал на Yale в течении его карьеры, поднимая к ряду полного профессора в 1988. После получать его степень бакалавра от коллежа Dartmouth в hanover, Нью Хемпшир, и его медицинском степени от школы университета N6h Иорка микстуры в N6h Иорке, Др. Саррел завершило его internship на стационаре sinai держателя в N6h Иорке и его месте жительства в obstetrics и Gynecology на центре Ыале-Novogo haven медицинском в новом haven. После его назначения к факультету Yale в 1969, вместе с Lorna Sarrel, он основал секс Yale консультируя обслуживание. В 1971, он и mrs. Саррел были натренированы в терапии секса William Оригиналом и virginia Johnson и в 1975-1976; Др. Саррел получило пожалование эрудита факультета учредительства Macy на один год на университете oxford в Англии, где он работал с john Bancroft в отделе психиатрии. В 1976, Др. Саррел начало программу менопаузы Yale и в 1982-1983, он посвятил sabbatical год к изучению менопаузы работая с Др. Малчолм Шюитеюеад на королях Коллеже Стационаре в london. Он был повышен к ряду полного профессора в 1988 на Yale. В 1989-1990 его назначение в сердечной микстуре на национальном институте сердца и легкя в london включило год исследования кардиологии в влияния овариальных инкретей на артериальной функции. Также в 1990, Др. Саррел начало его tenure как Чо-Direktor клиники Yale Ne1roo1-Gynecology, которая продолжается сегодня. В академическом годе 1996-1997, назначение как посещая профессор в отделе внутренне микстуры на стационаре columbia-Presbyterian-Presbyterian в N6h Иорке включило год изучения посвященный к понимать действия андрогенов. Он послужил как консультант к центру для другой микстуры на центре columbia-Presbyterian-Presbyterian медицинском, N6h Иорке, NY, с 1997. Он также послужил как консультант к центру для другой микстуры на стационаре Yale-Griffin, derby, connecticut с 1998, и с 2000 присутствовал на консультанте в отделе профилактической микстуры на стационаре Yale-Griffin. На Yale, Др. Саррел было Чо-Direktorom секса консультируя обслуживание с 1969 и директор программы изучения mid-life с 1984. Др. Саррел будет автором или соавтором над 200 медицинских статьей и глав для медицинских текстов и будет также соавтором 6 учебников отнесенных к менопаузе и к понимать сексуальные поведение и реакцию. Он был получателем 4 даров исследования от национальных институтов здоровья также,как много других даров исследования от учредительств и фармацевтическая промышленность. Его исследование во время прошлых 17 лет фокусировало на изучениях артериальных влияний инкретей и вопросов отнесенных к сексу и вызреванию. Он в настоящее время включается в изучения диетических interventions, и SERMs и phytoestrogens и их влияния на эндотелиальной клетке действуют. Он был одним из чо-issledovatele1 эстрогена женщин для пробы предохранения хода фондированной национальными институтами неврологического заболевания и ходом. Др. Саррел будет в настоящее время редактором MATURITAS, журналом международного общества менопаузы; Менопауза, журнал северного американского общества менопаузы; журнал исследования секса; журнал секса и супружеской терапии; и журнал Гендер-Speqificeski микстуры. Он будет также рецензентом рукописи для нового журнала Англии микстуры, американского журнала obstetrics и Gynecology, просмотрений эндокрина, сердечнососудистого исследования, журнала клинической эндокринологии и метаболизма, и американского журнала кардиологии.Read More
Chairman, Maimonides Medical center Distinguished Professor, SUNY Health Center Dept. of Obstetrics and Gynecology Brooklyn, NY (USA) Dr. Minkoff is a nationally recognized leader in the field of Maternal and Fetal Medicine, specializing in the field of high-risk pregnancies. His work and research in HIV and sexually transmitted diseases is known nationally and internationally both. He has authored more than 200 scientific articles, book chapters, research abstracts, clinical presentations, and multimedia educational tool. He is currently chairman of the department of obstetrics and gynecology at Maimonides Medical Center in Brooklyn, NY, since 1997. In 1992 he had received distinguished service professor award from SUNY HSCB. Other noteworthy awards were given for his work and research is, Assistant Secretary of Health Awards in 1991 and Phi Beta Kappa. Dr. Minkoff received his medical degree for Pennsylvania State Medical School in 1975. After his residency he then entered the highly regarded fellowship in Maternal and Fetal Medicine at SUNY HSCB KCHC in Brooklyn, New York. He is the editorial consultant for 20 journals and Chairs a study section on HIV for the National Institute of Health (NIH). He is also involved in the development of programs for Doctors of the World. Dr. Minkoff’s current interests include research and teaching on prevention of Mother-to-Child HIV transmission, high- risk pregnancies, development and strategy planning of the projects and programs to improve maternal health at local, national and international level.Read More
Associate Professor & Chief Technology Officer Department of Obstetrics and Gynecology Associate Professor, Department of Medical Education University of Michigan Medical School L4000 Women’s Hospital 1500 E. Medical Center Dr. Ann Arbor, MI, 48109 Phone: 734-936-3110 Fax: 734-936-7722 e-mail: immaya@umich.edu Dr. Maya Hammoud is Associate Professor of Obstetrics and Gynecology and Associate Professor of Medical Education at the University of Michigan Medical School. She is a fellow of the American College of Obstetrics and Gynecology and serves on the Board of Directors of the Association of Professors of Gynecology and Obstetrics (APGO). Dr. Hammoud completed her M.D. degree at the University of Michigan Medical School, graduating Alpha Omega Alpha and cum laude in 1996. Upon completion of her residency training in Obstetrics and Gynecology at the University of Michigan Hospital in 2000, she joined the faculty as assistant professor and the Director of the Obstetrics and Gynecology Clerkship. She then served as Assistant Dean for Student Programs and Interim Associate Dean for Student Programs prior to relocating to Qatar. In those roles, Dr. Hammoud introduced many curricular innovations and ran many teaching workshops for faculty and resident development. She is the recipient of many teaching awards including the APGO Excellence in Teaching Award. In 2006, Dr. Hammoud joined Weill Cornell Medical College in Qatar first as Associate Dean for Admissions and Student Affairs, and then as the Senior Associate Dean for Education. During that time, she was very active in promoting women’s health and wellness programs at the hospital and in the community. After 3 years in Qatar, Dr. Hammoud relocated back to her home in Michigan and rejoined the faculty at the University of Michigan Medical School. Among her clinical and research activities at the University of Michigan Hospital, Dr. Hammoud developed and directed the Middle Eastern Women’s Health Program which primary mission was to provide culturally sensitive health care services to women of Middle Eastern origin. She published on special health and cultural issues in the Arab and Muslim patient, and translated patient education materials from English into Arabic. In recognition of her contributions, Dr. Hammoud was awarded the Arab American and Chaldean Council’s Excellence in Health Care Award. Currently, she continues her work in this area by collaborating on a project with faculty in Qatar on developing culturally appropriate instruments for patients’ assessment of the quality of health care in the Middle East. Dr. Hammoud has published numerous papers in the field of medical education, as well as in obstetrics and gynecology with a focus on women’s health and cultural competence. She serves as a reviewer for many peer-reviewed journals and she is currently the Associate Editor for the International Journal of Gynecology and Obstetrics.Read More
Director of Prenatal Diagnosis and Fetal Therapy Unit Assistant Professor of Obstetrics and Gynecology Department of Gynecological Science and Human Reproduction, Section of Maternal and Fetal Medicine University of Padua School of Medicine via Giustiniani N 3, Padua, 35128, Italy Phone: +39-339-8146745 Fax: +39-049-8211842 email: ecosmi@hotmail.com Erich Cosmi was born in Rome, Italy on December 1st, 1973. He entered the school of Medicine and Surgery at the University of Rome «La Sapienza», Rome, Italy in the 1993-1994 academic year, and was graduated on July 13th, 1999 summa with Laude, discussing his scientific work entitled: new therapeutical prevention of NRDS by in-utero surfactant administration. During his scholarship, Erich Cosmi was invited for three consecutive periods (1994-1996-1998), each period lasting three months, at the Yale University School of Medicine, Connecticut, USA, where he worked with Dr. Gabor Huszar in the Physiology Sperm laboratory and entered in a Research program concerning Reproductive Medicine. During his scholarship in Italy he attended as a student in the following Departments: Department of Anatomy: 1994-1995 Department of Pediatric Surgery: 1996-1997 Department of Anesthesiology: 1997-1998 Department of Obstetrics and Gynecology: 1998-1999 After his graduation in Medicine he attended the rotation as a Medical Doctor for 6 months in Internal Medicine, General Surgery, Pediatric and Ob/Gyn, Emergency and intensive Care Unit Departments. In the academic year of 1999-2000 he entered the residency school in Ob/Gyn at the University of Rome «Tor Vergata», Rome, Italy. In April 2001 he was appointed Assistant Professor in the Department of Obstetrics and Gynecology at the Virginia University (USA) School of Medicine for 3 years, were he was involved in many research projects in maternal-fetal medicine. From 2001 to 2004 was appointed Assistant Professor of Obstetrics and Gynecology and Associate Chief of MFM at the University of Sassari School of Medicine (Italy). He is assistant researcher at the Yale University School of medicine, Connecticut, USA. He is supervisor for Fetal Anemia at the University of Rome La Sapienza, Rome, Italy. From September 1st 2001 he was appointed as Assistant Professor of Obstetrics and Gynecology in University of Sassari School of Medicine, Italy. Till November 2001 he was involved with the residency program development in Obstetrics and Gynecology at the University of Sassari School of Medicine. From November 1st 2004 he was appointed Assistant Professor of Obstetrics and Gynecology in University of Padua School of Medicine. Erich Cosmi is author of 220 publications, with Impact Factor of 135, Citation Index of 324 and H- index of 10. From 2005 is Visiting Professor at the III University of Athens, Greece. From 13/09/05 is Tresourer and Counselor of the Italian Society of Maternal Fetal Medicine. International Member of the International Society of Ultrasound in Obstetrics and Gynecology from 2000; Member of The American Institute of Ultrasound in Medicine from 2005. Honorary Member of The Academy of Medicine of Serbia Montenegro. Expert Referee for ECM in Medicine appointed from 2005 by the Ministry of Health. From 2007 he is listed in the following encyclopedias: Who is Who in the World, Who is Who in Science and Engineering, Who is Who in America. From 2007 he is Director of the prenatal diagnosis and fetal therapy Unit in the Department of Obstetrics and Gynecology at Padua University.Read More
Department of Obstetrics and Gynecology St. Elizabeth’s Medical Center Boston, MA (USA) Education and Training: Undergraduate, University of Massachusetts, BS, Cum Laude, Biochemistry, 1986-90 Graduate, Albany Medical College, MD, 1992-96 Post Graduate, New England Medical Center, PGY-1 Obstetrics & Gynecology, 7/96-7/97 Post Graduate, New England Medical Center, Resident Obstetrics & Gynecology, 7/97-6/00 Appointments and Positions: Assistant Clinical Professor, Tufts University School of Medicine, 2000-present Caritas St. Elizabeth’s Medical Center, Student third year clinical rotation Coordinator, 2000-2003 Regis College, Nurse Practitioner program, Outpatient preceptor, 2007-present Certification and Licensure: Massachusetts State License #205483, 1996 American Board of Obstetrics and Gynecology, 2003 Membership In Professional Societies: American College of Obstetrics and Gynecology (Fellow), 2002-present Massachusetts Medical Society, 1998-present American Medical Society, 2005-present Academic Interests: Diagnosis and management of cervical disease St. Elizabeth’s Medical Center is devoted to women’s health care issues and welcomes projects related to safe motherhood from all over the world. Our residency program has residents from various countries and ethnic backgrounds. Our diversity is our strength.Read More
12 October, 2002 Mr. Paul Hoeffel Chief, NGO Section United Nations New York, NY 10017 Dear Sir: Please accept this letter of recommendation for the Women’s Health and Education Center of Springfield, Massachusetts. I have met with Dr. Rita Luthra on several occasions and understand the mission of the Center. It is my judgment that the Center is well qualified to be an accredited NGO to the DPI of the United Nations. Dr. Luthra has attended and participated in meetings of the UNA/USA and the Connecticut Division of our national organization. The Center is developing a useful and ambitious worldwide ob/gyn information system. If you have any questions, I would be pleased to respond. Sincerely, Irving Stolberg President, Connecticut Division UNA/USARead More
Professor of Obstetrics and Gynecology Chief, Division of Maternal-Fetal Medicine University of Utah Health Sciences Center (UUHSC) 30 North 1900 East SOM 2B200 Salt Lake City, UT 84132 (USA) Tel: 801-585-5156 Fax: 801-585-2594 E-mail: robert.silver@hsc.utah.edu Education and Training: INSTITUTION AND LOCATION DEGREE YEAR (s) FIELD OF STUDY University of Pennsylvania, Philadelphia, PA BA 1982 Microbiology Medical College of Pennsylvania, Philadelphia, PA MD 1986 Medicine University of Colorado Health Sciences Center, Denver, CO Residency 1986-1990 Obstetrics and Gynecology University of Utah Health Sciences Center (UUHSC), Salt Lake City, UT Fellowship 1990-1994 Maternal-Fetal Medicine A. Positions and Honors Positions 1990-1991 Clinical Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1992-1994 Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1994-1998 Assistant Professor, Department of Ob/Gyn, UUHSC, SLC, UT 1998-2006 Associate Professor with tenure, Department of Ob/Gyn, UUHSC, SLC, UT 2006-present Professor with tenure, Department of Ob/Gyn, UUHSC, SLC , UT 1995-2003 Residency Director, Department of Ob/Gyn, UUHSC, SLC, UT 2001-present Medical Director of Labor and Delivery, UUHSC, SLC, UT 2000-present Division Chief, Maternal Fetal Medicine, Department of Ob/Gyn, UUHSC, SLC, UT Honors 1985 Kurt Pauker Achievement Award for Excellence in Microbiology 1986 Alpha Omega Alpha 1993-1998 Research Scientist Development Program, National Institutes of Health 2000 Poster Award (best of session): IgA beta-2-glycoprotein-I Antibodies are Elevated in Women with Unexplained Recurrent Spontaneous Abortion and Unexplained Fetal Death, Society for Gynecologic Investigation 2001 Poster Award (best of session): Heparin-induced Thrombocytopenia is Rare in Pregnancy, Society of Perinatal Obstetricians 18th Annual Meeting 2003 Poster Award (best of meeting): Stillbirth in Utah from 1995-2001 B. Peer-Reviewed Publications Select peer-reviewed publications (in chronological order) Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. (1993). Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993; 14:615-25. Edwin SS, Branch DW, Scott JR, Silver RM, Mitchell MD. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. Am J Reprod Immunol 1993;30: 154-9. Silver RM, Draper ML, Scott JR, Lyon JL, Byrne SL, Ashwood EA, Branch DW. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: A harbinger of fetal death. Obstet Gynecol 1993; 83:150-5. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historical cohort study. Obstet Gynecol, 1994;83:372-7. Mitchell MD, LaMarche S, Adamson S, Coulam C, Silver RM, Edwin SS. Regulation of intrauterine prostaglandin biosynthesis interactions between protein kinase C and interleukin 1Β. Prost Leuk EFA 1994;50:137-40. Silver RM, Edwin SS, Trautmna MS, Simmons DL, Branch DW, Dudley DJ, Mitchell MD. Bacterial lipopolysaccharide mediated fetal death: Production of a newly-recognized form of inducible cyclooxygenase (COX-2) in murine deciduas in response to lipopolysaccharide. J Clin Invest 1995;93:725-31. Silver RM, Pierangelli SS, Gharavai AE, Harris EN, Edwin SS, Salafia CM, Branch DW. Induction of high levels of anticardiolipin antibodies in mice by immunization with Β2-glycoprotein 1 does not cause fetal death. Am J Obstet Gynecol 1995;173L1410-5. Silver RM, Porter TF, van Leeuwen I, Coulam C, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: Clinical consequences of low titers. Obstet Gynecol 1996;87:494-500. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93. Edwin SS, Branch DW, Scott JR, Silver RM, Dudley DJ, Mitchell MD. Cyclosporin A inhibits prostaglandin E2 production by fetal amnion cells in response to various stimuli. Prostaglandins 1996;52:51-61. Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-13. Branch DW, Silver RM, Pierangeli SS, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant are not associated with recurrent pregnancy loss. Obstet Gyencol 1997;89:549-55. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediate fetal death: The role of interleukin-1. Am J Obstet Gynecol 1997;176:544-9. Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who test negative for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997;176:628-33. Silver RM, Smith LA, Edwin SS, Oshiro BT, Scott JR, Branch DW. Variable effects of immunoglobulin G fractions from women with antiphospholipid antibodies on murine pregnancy. Am J Obstet Gynecol 1997;177:229-33. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver RM, Kwad J, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997;38:57-74. Edwin SS, Mitchell MD, Silver RM, Branch DW, Dudley DJ. Ceramide stimulates prostaglandin production by human amnion and decidual cells J Soc Gynecol Invst 1997;4:274-8. Gharavi AE, Cucurull E, Tang H, Silver RM, Branch DW. Effect of antiphospholipid antibodies on beta-2-glycoprotein I-phospholipid interaction. Am J Reprod Immunol 1998;39:310-5. Kutteh WH, Rote NS, Silver RM. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1999;41:133-154. Pregnancy loss study group (Branch DW, Druzin M, El-Sayed Y, Esplin MS, Hrager J, Peaceman AM, Silver RK, Silver RM, Spinnato J). A multicenter, controlled, pilot study of intravenous immune globulin treatment antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 2000;182:122-7. Van-Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of gestational tissues from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004;25:642-8. Ornoy A, Chen L, Silver RM, Mosmann TR, Miller RK. Maternal autoimmune diseases and immunologically-induced embryonic and feto-placental damage. Birth Defects Res Part A Clin Mol Teratol 2004;70:71-81. Frias AE, Luikenaar RA, Sullivan AE, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104:521-6. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Does recurrent aneuploidy contribute to recurrent miscarriage? Obstet Gynecol 2004;10:784-8. Sullivan AE, Nelson L, Rice JA, Porter TF, Branch DW, Silver RM. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death. Am J Reprod Immunol 2005;54;1-4. Sullivan AE, Nelson L, Silver RM, Frias AE, Porter TF, Branch DW. The aryl hydrocarbon receptor nuclear tranlsocator gene polymorphism in patients with recurrent miscarriage. Am J Reprod Immunol 2006;55(1): 51-3 Silver RM, Landon MB, Rouse DC, Leveno JK, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107(6): 1226-32. Silver RM. Fetal Death. Obstet Gynecol 2007;109(1):153-67. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44. Warren JE, Silver RM, Nelson L, Dalton J, Porter TF, Branch DW. Cervical insufficiency: a genetic condition? Collagen 1?1 intron SP1 and transforming growth factor-? ARG-25-PRO polymorphisms in women with cervical insufficiency. Obstet Gynecol 2007;110:619-24. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Pediatrics 2007;120:609-16. Holmgren C, Esplin MS, Hamblin S, Esplin MS, Molenda M, Silver RM. Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model. J Reprod Immunol 2008; Epub, April 21. Silver RM. New anticoagulants and pregnancy. Obstet Gynecol 2008;112:419-20. Silver RM. Immune activation early in pregnancy: trouble down the road. Am J Obstet Gynecol 2008, 199;327-8. Holmgren C, Porter TF, Varner MW, Aagard K, Silver RM. Hyperemesis in pregnancy: A comparison of treatment strategies. Am J Obstet Gynecol, 2008;198:56e1-4. Turok DK, Gurtcheff S, Esplin MS, Shah M, Simonsen SE, Shah M, Trauscht-Van Horn J, Silver RM. Second trimester termination of pregnancy: A review by site and procedure type. Contraception 2008;77:155-61 Peltier MR, Faux DS, Hamblin SD, Cooper C, Silver RM, Esplin MS. Effect of aspirin treatment on TNF-? Production by women with a history of preterm birth. J Reprod Immunol 2009;80:109-14. Warren JE, Silver RM, Branch DW, Porter TF. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with thrombophilias. Am J Obstet Gynecol 2009;200:281.e1-5. Warren JE, Nelson L, Esplin MS, Silver RM. Interleukin-10 polymorphisms and cervical insufficiency. Am J Obstet Gynecol 2009;201:372-4. Manuck TA, Eller AG, Esplin MS, Stoddard G, Varner MW, Silver RM. Outcomes of expectantly managed preterm premature rupture of membranes occurring ? 24 weeks gestation. Obstet Gynecol 2009;114:29-37. Reddy UM, Goldenberg R, Silver R, Smith GCS, Pauli RM, Wapner RJ, et al. Stillbirth classification: developing an international consensus for research: Executive summary of NICHD workshop. Obstet Gynecol 2009;114:901-14. Manuck TA, McLean, Varner MW, Silver RM. Preterm premature rupture of membranes: does the duration of latency influence neonatal outcome? Am J Obstet Gynecol 2009;201:414-6. Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Array comparative genomic hybridization (aCGH) for genetic evaluation of fetal loss between 10 and 20 weeks gestation. Obstet Gynecol 2009;114:1093-1102. Clark EAS, Lacoursiere DY, Byrne JLB, Ponder R, Silver RM, Esplin MS. Reliability of fetal MCA velocity: a randomized controlled trial of sonographer training. J Ultrasound Med 2009;28:19-25. Grosvenor Eller A, Silver RM, Zempolich K, Soisson P, Simonson SE. Optimal management of placenta accreta. Br J Obstet Gynecol 2009;116:648-54. Peltier MR, Faux DS, Hamblin SD, Silver RM, Esplin MS. Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. In press, J Reprod Immunol. Silver RM, Zhao Y, Spong C, Caritis SN, Sibai B, Wendel G Jr., et al. Prothrombin gene G20210A mutation and obstetric complications: a prospective cohort. In press, Obstet Gynecol. C. Research Support Ongoing Support NIH/NICHD 1U10HD063053-01 Preterm Birth in Nulliparous Women: An Understudied Population (Silver)12/01/2009-11/30/2014 This Network will design and execute a prospective, longitudinal cohort study of 10,000 nulliparous women. The research protocols developed will determine characteristics that influence and/or predict adverse pregnancy outcomes in nulliparous women including genetics, epigenetics, physiological response to pregnancy, interaction with environmental exposures, fetal growth and development, and placental development and function. Role: PI NIH/NICHD 3U10HD045944-05S2 Research on the Scope and Causes of Stillbirth in the United States (Silver)09/26/2003—07/31/2009NCX The major goals of this project are to develop a network of collaborating academic centers to study the extent and causes of stillbirth and to develop methods for stillbirth prevention. Role: PI NIH/NICHD HHSN267200603423C / N01DK63423 (Silver)09/30/2006-09/29/2011 The Effects of Aspirin in Gestation and Reproduction The purpose of this contract is to evaluate the effect of daily low-dose aspirin on all phases of reproduction beginning at preconception and continuing throughout pregnancy, including implantation and live births. Role: PIRead More
President, Royal College of Obstetricians and Gynaecologists (RCOG), 2013-2016 27 Sussex Place Regent’s Park London NW1 4RG; U.K. T: +44 20 7772 6250 David is a consultant uro-gynaecologist at the Liverpool Women’s Hospital and was its Medical Director for 17 years from 1993 to 2010 prior to becoming Vice President (Clinical Quality) of the RCOG. During his tenure he published High Quality Women’s Health (2011)–a proposal for developing a public health life-course approach to care combined with implementing networks for delivery. He championed the production of the first RCOG national Maternity Clinical Indicators Report for England. This will act as a template for further national reports to include other aspects of clinical performance. David has promoted clinical quality initiatives and audit at a national level and encouraged the College to develop quality improvement projects (Each Baby Counts and Perineal Trauma – 2015). His main interests lie in all aspects of education, training, clinical quality and safety and the implementation of national guidance. He has a strong track record in workforce planning and authored the RCOG report on the Future Workforce in Obstetrics and Gynaecology for England and Wales (2009). This has led to a working party to review national standards for maternity care and also gynaecology with a particular emphasis on service delivery; Safer Women’s Healthcare. Dr. Richmond has been keen to improve the relationship between the College and its membership and is implementing the recommendations of its Governance Review and subsequent Representation Working Party which has proposed greater openness and transparency of College working and Council meetings. He has also opened the discussion on increasing the electorate to its members potentially on a global footing. He is Vice Chair of the Academy of Medical Royal Colleges and Council member and Fellow of the Faculty of Medical Leadership and Management. He has developed strong links with the UK Government ministers in areas of mutual benefit, the Care Quality Commission and NHS England. David has represented the RCOG on independent national reviews in Scotland and England with regard to surgical mesh use for incontinence and prolapse and is co-chair of the models of care stream in the NHS Maternity Review. His main interests outside medicine involve his family and the outdoors including his garden, golf, running and climbing.Read More
